Comi, G; Carrá, A; Fazekas, F; Rieckmann, P; Bajenaru, O; Hillert, J; Elovaara, I; Young, C; Wynn, D; King, J; Lubetzki, C; Hartung, HP; Myhr KM; Montalban, X; Komoly, S; Filippi, M; for the PreCISe study group.
Treatment with glatiramer acetate delays conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome: subgroup analyses.
Multiple Sclerosis2008; 14(S1):S38-S39.-World Congress on Treatment and Research in Multiple Sclerosis: ACTRIMS + ECTRIMS + LACTRIMS; SEP 17-20, 2008; Montreal, CANADA.
[Poster]
Web of Science